stars 1 stars 2 stars 3

Founded in 2000, Diverchim is a Small Molecule Drug Substance CDMO that specializes in complex chemistry. Diverchim offers premium services for the development and the manufacturing of small quantities APIs, from early phases to commercial. Our customers include pharma companies and emerging Biotechs involved in developing New Chemical Entities. We have a strong focus on high added-value APIs (rare diseases and orphan drugs, radiopharmaceuticals). Our capabilities include various cGMP manufacturing suites: small scale (mg to dozens of grams), kilolabs (up to a few kilos) and pilot plant (dozens of kilos).

DIVERCHIM CDMO Questions

The DIVERCHIM CDMO annual revenue was $6.2 million in 2026.

Francois MacArez is the CEO of DIVERCHIM CDMO.

40 people are employed at DIVERCHIM CDMO.

DIVERCHIM CDMO is based in Montataire, Hauts-de-France.

The NAICS codes for DIVERCHIM CDMO are [325, 3254, 32, 32541].

The SIC codes for DIVERCHIM CDMO are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users